Vol. 12, Issue 5 (2024)

Broca's Aphasia, also known as Non-Fluent Aphasia, is a neurological disorder characterized by difficulties in speech production while comprehension remains intact. This review explores the symptoms, etiology, diagnosis, and therapeutic interventions associated with Broca's Aphasia. Patients with Broca's Aphasia exhibit reduced speech fluency, telegraphic speech, limited vocabulary, articulation problems, agrammatism, and non-verbal communication difficulties. The severity and specificity of symptoms vary, necessitating comprehensive assessments by speech-language pathologists. Traditionally linked to damage in Broca's area, recent research indicates diverse etiologies, including strokes, traumatic brain injuries, tumors, autoimmune encephalitis, and paraneoplastic syndromes. However, precise mechanisms triggering Broca's Aphasia beyond focal brain lesions are yet to be comprehensively elucidated. Diagnosis involves a comprehensive evaluation using standardized tests, clinical observations, and neuroimaging techniques. Key diagnostic tools include the Western Aphasia Battery and the Boston Diagnostic Aphasia Test. Despite advancements, the lack of standardized therapeutic measures poses challenges in assessing universal effectiveness. Therapeutic interventions, such as melodic intonation therapy and constraint-induced aphasia therapy, aim to enhance communication skills. However, the absence of standardized approaches highlights a research gap in establishing universal protocols for effective management.

This review underscores the complexity of Broca's Aphasia, emphasizing the need for a deeper understanding of its symptoms and etiology. The absence of standardized therapeutic measures calls for further research to address this gap and enhance diagnostic accuracy and treatment outcomes. Increased awareness among healthcare professionals and society is crucial for providing adequate support to individuals affected by this challenging neurological disorder.